MedPath

DEVELOPMENT OF AMA ASSESSMENT TOOL AND KNOW THE EFFECT OF AMA ON PRO-INFLAMATORY MARKER

Not Applicable
Conditions
Health Condition 1: R768- Other specified abnormal immunological findings in serumHealth Condition 2: K928- Other specified diseases of the digestive system
Registration Number
CTRI/2023/09/057837
Lead Sponsor
KLE Academy of Higher education and research belagavi karnataka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Group A

1.Individual between 20 years to 30 years of age and with signs and symptoms of AMA (Ashtang hridya)

2.With no systemic diseases.

Group B

•Healthy individual with no symptoms of ama and no systemic disease/inflammation.

Exclusion Criteria

?Patients >20 years and <30 years of age .

?Patients with Samshrishta Dosha (chronic stage).

?Patients with systemic disease like diabetes, kidney disease, cancer, cardiovascular disease, dyslipidemia, rheumatoid arthritis, IBD, Alzheimer’s and Parkinson’s disease.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
association of inflammatory markers with amaTimepoint: after the analysis of the result i.e at 6 months
Secondary Outcome Measures
NameTimeMethod
ama association with digestive inflammtory marker at the end of the studyTimepoint: after the analysis of the at 6 months
© Copyright 2025. All Rights Reserved by MedPath